Previously, Ma and colleagues (Ma, 2013 #771) demonstrated that treating diet-induced obese mice with the FXR agonist GW4064 reversed hepatic steatosis and reduced plasma lipid levels. The gene discussed is NR1H4; the disease is fatty liver disease.